Christopher Kane, of Pfizer Global Research and Development, presented his work on targeted drug delivery yesterday at Informa’s Nuclear Receptor conference in Berlin. Kane highlighted the importance of a drugs therapeutic index: TI = efficacy/toxicity.
For more on Tim Monran's blog post, visit:
http://blog.accelrys.com/2010/...ivery-nanoparticles/